Clevidipine
FDA-approved product (emulsion, intravenous), marketed as Cleviprex.
- Registered studies
- 34
- Lab records
- 0
- Pathogens at ≥40%
- 3 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Cardiovascular disease
Indications ChEMBL records as approved, from FDA and DailyMed labels.
- WHO therapeutic group
- Dihydropyridine derivatives
- FDA pharmacologic class
- Dihydropyridine Calcium Channel Blocker FDA label ↗
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against M. tuberculosis, MRSA and E. coli. It was surfaced computationally for further investigation; it is not an established treatment for these infections.
AI-predicted activity
AI prediction · nothing measured- MRSA52.2% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli41.0% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- K. pneumoniae13.4% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis48.4% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
34registered studies name this medicine, for any condition. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredAutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Clevidipine with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- DichlorphenamideExisting use: Glaucoma73.9% AI-predicted activityagainst M. tuberculosisLab records exist2 registered studies
- Tamsulosin HydrochlorideExisting use: Benign prostatic hyperplasia, Prostate carcinoma73.2% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Thiethylperazine MalateExisting use: Allergic disease71.8% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- SaquinavirExisting use: HIV infection, HIV-1 infection, Viral disease71.5% AI-predicted activityagainst M. tuberculosis50+ registered studies
- AvacopanExisting use: Anti-neutrophil antibody associated vasculitis, Anti-neutrophil cytoplasmic antibody-associated vasculitis, Granulomatosis with Polyangiitis and 1 more71.3% AI-predicted activityagainst M. tuberculosis26 registered studies
- Lasmiditan SuccinateExisting use: Migraine disorder71.0% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- SotorasibExisting use: Neoplasm, Non-small cell lung carcinoma71.0% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Vinblastine SulfateExisting use: Classic Hodgkin lymphoma, Fungal infectious disease, Hodgkins lymphoma and 3 more70.8% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Haloperidol DecanoateExisting use: Conduct disorder, Mental or behavioural disorder, Psychosis and 4 more70.1% AI-predicted activityagainst M. tuberculosis50+ registered studies
- HydrochlorothiazideExisting use: Angina pectoris, Cardiovascular disease, Chronic kidney disease and 9 more70.1% AI-predicted activityagainst M. tuberculosis50+ registered studies
- TolvaptanExisting use: Autosomal dominant polycystic kidney disease, Cardiovascular disease, Congestive heart failure and 4 more70.0% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Larotrectinib SulfateExisting use: Abdominal Neoplasms, Cancer, Metastasis and 1 more69.2% AI-predicted activityagainst M. tuberculosis5 registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
An Open-label Trial of Clevidipine for Controlled Hypotension During Spinal Fusion
NCT01645111 · start 2012-06
Registered record
- Registry ID
- NCT01645111
- Conditions
- Neuromuscular Scoliosis
- Interventions
- Clevidipine
- Study type
- INTERVENTIONAL
- Phase
- Phase 2 / Phase 3
- Registry status
- Completed
- Start
- 2012-06
- Completion
- 2013-12
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNeuromuscular ScoliosisInterventionClevidipinePhasePhase 2 / Phase 3Registry statusCompletedPre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection
NCT01480531 · start 2011-12
Registered record
- Registry ID
- NCT01480531
- Conditions
- Aorta Aneurysm; Dissection of Aorta
- Interventions
- Clevidipine
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Withdrawn
- Start
- 2011-12
- Completion
- 2012-12
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAorta Aneurysm; Dissection of AortaInterventionClevidipinePhaseNot applicableRegistry statusWithdrawnThe Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients
NCT01526876 · start 2011-11
Registered record
- Registry ID
- NCT01526876
- Conditions
- Hypertension
- Interventions
- clevidipine butyrate
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Withdrawn
- Start
- 2011-11
- Completion
- 2012-12-19
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypertensionInterventionclevidipine butyratePhasePhase 4Registry statusWithdrawnThe Energy Dose Study
NCT01369147 · start 2011-07
Registered record
- Registry ID
- NCT01369147
- Conditions
- Critical Illness
- Interventions
- Parenteral Nutrition; Propofol; Clevidipine; Dextrose-containing IV Fluids; Enteral feeding
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Terminated
- Start
- 2011-07
- Completion
- 2014-12-02
- Enrolment
- 12
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCritical IllnessInterventionParenteral Nutrition; Propofol; Clevidipine; Dextrose-containing IV Fluids +1 morePhasePhase 2Registry statusTerminatedThe Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy
NCT01042574 · start 2010-05
Registered record
- Registry ID
- NCT01042574
- Conditions
- Hypertension; Intracranial Hemorrhage; Subarachnoid Hemorrhage
- Interventions
- Clevidipine butyrate
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Withdrawn
- Start
- 2010-05
- Completion
- 2010-12-31
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypertension; Intracranial Hemorrhage; Subarachnoid HemorrhageInterventionClevidipine butyratePhasePhase 4Registry statusWithdrawnThe Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy
NCT01910532 · start 2010-04
Registered record
- Registry ID
- NCT01910532
- Conditions
- Hypertension
- Interventions
- Clevidipine
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Withdrawn
- Start
- 2010-04
- Completion
- 2012-11
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypertensionInterventionClevidipinePhasePhase 4Registry statusWithdrawnA Safety and Efficacy Study of Blood Pressure Control in Acute Aortic Emergencies - A Pilot Study (PROMPT)
NCT01033370 · start 2009-11
Registered record
- Registry ID
- NCT01033370
- Conditions
- Aortic Aneurysm; Aortic Disease
- Interventions
- clevidipine.
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Terminated
- Start
- 2009-11
- Completion
- 2012-08
- Enrolment
- 5
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAortic Aneurysm; Aortic DiseaseInterventionclevidipine.PhasePhase 4Registry statusTerminatedClevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed
NCT01121458 · start 2009-09
Registered record
- Registry ID
- NCT01121458
- Conditions
- Hypertension, Pulmonary
- Interventions
- Clevidipine
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2009-09
- Completion
- 2013-04
- Enrolment
- 12
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypertension, PulmonaryInterventionClevidipinePhasePhase 4Registry statusCompletedA Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients
NCT00952081 · start 2009-07
Registered record
- Registry ID
- NCT00952081
- Conditions
- Hypertension; Brain Tumor; Epilepsy
- Interventions
- Clevidipine
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2009-07
- Completion
- 2010-02
- Enrolment
- 22
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypertension; Brain Tumor; EpilepsyInterventionClevidipinePhasePhase 4Registry statusCompletedSafety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage
NCT00978822 · start 2009-06
Registered record
- Registry ID
- NCT00978822
- Conditions
- Subarachnoid Hemorrhage; Hypertension
- Interventions
- Clevidipine butyrate injectable emulsion
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Terminated
- Start
- 2009-06
- Completion
- 2012-12
- Enrolment
- 5
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSubarachnoid Hemorrhage; HypertensionInterventionClevidipine butyrate injectable emulsionPhasePhase 2Registry statusTerminatedClevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)
NCT00803634 · start 2008-12
Registered record
- Registry ID
- NCT00803634
- Conditions
- Hypertension; Heart Failure
- Interventions
- Clevidipine; Standard of Care IV antihypertensive
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2008-12
- Completion
- 2012-03
- Enrolment
- 117
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypertension; Heart FailureInterventionClevidipine; Standard of Care IV antihypertensivePhasePhase 3Registry statusCompletedClevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT)
NCT00799604 · start 2008-11
Registered record
- Registry ID
- NCT00799604
- Conditions
- Hypertension
- Interventions
- clevidipine
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2008-11
- Completion
- 2009-10
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypertensionInterventionclevidipinePhasePhase 2Registry statusCompletedClevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)
NCT00666328 · start 2008-06
Registered record
- Registry ID
- NCT00666328
- Conditions
- Hypertension; Hemorrhage
- Interventions
- clevidipine
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2008-06
- Completion
- 2010-04
- Enrolment
- 37
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypertension; HemorrhageInterventionclevidipinePhasePhase 3Registry statusCompletedClevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)
NCT00369837 · start 2006-09
Registered record
- Registry ID
- NCT00369837
- Conditions
- Hypertension
- Interventions
- clevidipine
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2006-09
- Completion
- 2007-02
- Enrolment
- 131
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypertensionInterventionclevidipinePhasePhase 3Registry statusCompletedClevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)
NCT00093912 · start 2004-06
Registered record
- Registry ID
- NCT00093912
- Conditions
- Hypertension
- Interventions
- clevidipine; sodium nitroprusside
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2004-06
- Completion
- 2006-11
- Enrolment
- 739
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypertensionInterventionclevidipine; sodium nitroprussidePhasePhase 3Registry statusCompleted